Scholar Rock Holding (SRRK) Cash from Operations (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.75% |
| Dec 31, 2025 | -9.54% |
| Sep 30, 2025 | 10.42% |
| Jun 30, 2025 | 2.20% |
| Mar 31, 2025 | -58.90% |
| Dec 31, 2024 | 5.61% |
| Sep 30, 2024 | -6.62% |
| Jun 30, 2024 | 1.18% |
| Mar 31, 2024 | -33.30% |
| Dec 31, 2023 | -15.73% |
| Sep 30, 2023 | 0.85% |
| Jun 30, 2023 | 24.40% |
| Mar 31, 2023 | -48.94% |
| Dec 31, 2022 | -9.15% |
| Sep 30, 2022 | 23.77% |
| Jun 30, 2022 | 18.39% |
| Mar 31, 2022 | -31.15% |
| Dec 31, 2021 | 9.79% |
| Sep 30, 2021 | -13.09% |
| Jun 30, 2021 | -19.85% |
| Mar 31, 2021 | -34.84% |
| Dec 31, 2020 | 15.86% |
| Sep 30, 2020 | -18.00% |
| Jun 30, 2020 | -852.16% |
| Mar 31, 2020 | 116.41% |
| Dec 31, 2019 | -6.32% |
| Sep 30, 2019 | 7.89% |
| Jun 30, 2019 | -5.64% |
| Mar 31, 2019 | -128.19% |
| Dec 31, 2018 | 711.27% |
| Sep 30, 2018 | 22.48% |
| Jun 30, 2018 | -17.62% |
| Mar 31, 2018 | -63.16% |
| Dec 31, 2017 | -5.45% |